🔗 Permalink

Inventor profile of:

David S. Casebier

City:

Carlisle, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-05-29

Top Assignees for applications by David S. Casebier

The entities that hold a legal rights for patent applications filed by inventor Casebier David S.:

Lantheus Medical Imaging, Inc. 25 North Billerica, MA United States
ArQule, Inc. 4 Woburn, MA United States
Wyeth 3 Madison, NJ United States
Lantheus Medical Imaging, Inc. 3 Bedford, MA United States
Wyeth LLC 2 Madison, NJ United States
Tokai Pharmaceuticals, Inc. 1 Cambridge, MA United States
BRISTOL-MYERS SQUIBB PHARMA COMPANY 1 Princeton, NJ United States
Lantheus Medical Imaging 1 N. Billerica, MA United States
Lantheus Medical Imaging, Inc. 1 North Billrerica, MA United States
TOKAI PHARMACEUTICALS, INC. 1 Boston, MA United States

Recent patent applications by Casebier David S.

David S. Casebier from Carlisle, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-29

US20250170282A1

Human necessities

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

#2 | 2025-05-22

US20250161500A1

Human necessities

LIGANDS FOR IMAGING CARDIAC INNERVATION

#3 | 2022-10-27

US20220339303A1

Human necessities

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

#4 | 2022-09-15

US20220288243A1

Human necessities

LIGANDS FOR IMAGING CARDIAC INNERVATION

#5 | 2021-09-30

US20210300878A1

Chemistry; metallurgy

CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING

#6 | 2020-12-24

US20200397927A1

Human necessities

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

#7 | 2019-05-02

US20190127333A1

Chemistry; metallurgy

Contrast agents for myocardial perfusion imaging

#8 | 2018-12-06

US20180344881A1

Human necessities

FORMULATIONS FOR 2-HETEROARYL SUBSTITUTED BENZOFURANS

#9 | 2018-11-29

US20180339070A1

Human necessities

Ligands for imaging cardiac innervation

#10 | 2018-05-17

US20180133347A9

Human necessities

CONTRAST AGENTS FOR APPLICATIONS INCLUDING PERFUSION IMAGING

#11 | 2018-01-11

US20180009763A1

Chemistry; metallurgy

Contrast agents for myocardial perfusion imaging

#12 | 2017-09-21

US20170266326A1

Human necessities

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

#13 | 2017-02-02

US20170029386A9

Chemistry; metallurgy

N-alkoxyamide conjugates as imaging agents

#14 | 2017-01-12

US20170008920A1

Chemistry; metallurgy

MAMMALIAN METABOLITES OF STEROIDS

#15 | 2016-12-15

US20160361448A1

Human necessities

Contrast agents for applications including perfusion imaging

#16 | 2016-06-30

US20160185737A1

Chemistry; metallurgy

N-alkoxyamide conjugates as imaging agents

#17 | 2016-05-12

US20160130235A1

Chemistry; metallurgy

Contrast agents for myocardial perfusion imaging

#18 | 2015-04-02

US20150094465A1

Chemistry; metallurgy

N-alkoxyamide conjugates as imaging agents

#19 | 2015-03-19

US20150078997A1

Human necessities

N-alkoxyamide conjugates as imaging agents

#20 | 2014-12-18

US20140371181A1

Chemistry; metallurgy

Prodrugs of steroidal CYP17 inhibitors/antiandrogens

#21 | 2014-11-06

US20140328756A1

Human necessities

Compositions, methods, and systems for the synthesis and use of imaging agents

#22 | 2014-01-30

US20140030189A1

Human necessities

Ligands for imaging cardiac innervation

#23 | 2013-11-28

US20130315822A1

Human necessities

N-alkoxyamide conjugates as imaging agents

#24 | 2013-01-31

US20130028837A1

Human necessities

CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING

#25 | 2012-12-27

US20120328514A1

Human necessities

N-alkoxyamide conjugates as imaging agents

#26 | 2012-11-08

US20120282331A1

Chemistry; metallurgy

MAMMALIAN METABOLITES OF STEROIDS

#27 | 2012-11-01

US20120276006A1

Chemistry; metallurgy

Contrast agents for myocardial perfusion imaging

#28 | 2011-04-21

US20110091374A1

Human necessities

Contrast agents for applications including perfusion imaging

#29 | 2011-02-10

US20110034513A1

Chemistry; metallurgy

Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production

#30 | 2010-09-02

US20100221182A1

Human necessities

Ligands for imaging cardiac innervation

#31 | 2010-01-28

US20100022594A1

Chemistry; metallurgy

Heterocyclic sulfonamide inhibitors of beta amyloid production

#32 | 2009-10-08

US20090252676A1

Chemistry; metallurgy

N-alkoxyamide conjugates as imaging agents

#33 | 2009-04-23

US20090104118A1

Human necessities

Contrast agents for myocardial perfusion imaging

#34 | 2008-05-15

US20080112884A1

Chemistry; metallurgy

Contrast agents for myocardial perfusion imaging

#35 | 2007-06-21

US20070140973A1

Human necessities

CONTRAST AGENTS FOR MYOCARDIUM PERFUSION IMAGING

#36 | 2007-02-15

US20070036716A1

Chemistry; metallurgy

Methods of making radiolabeled tracers and precursors thereof

#37 | 2006-04-20

US20060083681A1

Chemistry; metallurgy

Compounds for myocardial perfusion imaging

#38 | 2005-11-03

US20050244332A1

Human necessities

Contrast agents for myocardial perfusion imaging

#39 | 2005-09-08

US20050196813A1

Chemistry; metallurgy

Heterocyclic sulfonamide inhibitors of β amyloid production

#40 | 2005-09-01

US20050191238A1

Chemistry; metallurgy

Contrast agents for myocardial perfusion imaging

#41 | 2005-06-23

US20050136003A1

Human necessities

Novel chemical agents comprising a cardiotonic moiety and an imaging moiety and methods of their use

#42 | 2005-05-19

US20050106101A1

Chemistry; metallurgy

Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use

#43 | 2005-04-12

US10455674

Heterocyclic sulfonamide inhibitors of beta amyloid production

InventorID:

65694 ⎘